AbbVie, Inc. (ABBV)
255.48
-2.67
(-1.03%)
USD |
NYSE |
Aug 28, 16:00
255.52
+0.04
(+0.01%)
After-Hours: 20:00
AbbVie Cash and Short Term Investments (Quarterly) : 6.569B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.569B |
| March 31, 2026 | 9.391B |
| December 31, 2025 | 5.257B |
| September 30, 2025 | 5.671B |
| June 30, 2025 | 6.467B |
| March 31, 2025 | 5.176B |
| December 31, 2024 | 5.555B |
| September 30, 2024 | 7.285B |
| June 30, 2024 | 13.16B |
| March 31, 2024 | 18.07B |
| December 31, 2023 | 12.82B |
| September 30, 2023 | 13.29B |
| June 30, 2023 | 8.766B |
| March 31, 2023 | 6.722B |
| December 31, 2022 | 9.229B |
| September 30, 2022 | 11.88B |
| June 30, 2022 | 9.961B |
| March 31, 2022 | 7.572B |
| December 31, 2021 | 9.83B |
| September 30, 2021 | 12.25B |
| June 30, 2021 | 8.60B |
| March 31, 2021 | 9.777B |
| December 31, 2020 | 8.479B |
| September 30, 2020 | 7.95B |
| June 30, 2020 | 6.04B |
| Date | Value |
|---|---|
| March 31, 2020 | 41.14B |
| December 31, 2019 | 39.92B |
| September 30, 2019 | 10.65B |
| June 30, 2019 | 5.416B |
| March 31, 2019 | 5.228B |
| December 31, 2018 | 8.061B |
| September 30, 2018 | 8.785B |
| June 30, 2018 | 3.743B |
| March 31, 2018 | 9.474B |
| December 31, 2017 | 9.789B |
| September 30, 2017 | 9.554B |
| June 30, 2017 | 7.205B |
| March 31, 2017 | 6.248B |
| December 31, 2016 | 6.423B |
| September 30, 2016 | 7.95B |
| June 30, 2016 | 8.002B |
| March 31, 2016 | 8.60B |
| December 31, 2015 | 8.407B |
| September 30, 2015 | 9.249B |
| June 30, 2015 | 8.279B |
| March 31, 2015 | 7.924B |
| December 31, 2014 | 8.374B |
| September 30, 2014 | 10.32B |
| June 30, 2014 | 10.25B |
| March 31, 2014 | 9.10B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Biogen, Inc. | 1.285B |
| Gilead Sciences, Inc. | 4.882B |
| Regeneron Pharmaceuticals, Inc. | 8.005B |
| Amgen, Inc. | 13.99B |
| REGENXBIO, Inc. | 105.74M |